VAXIGRIP^®
(influenza virus)
SANOFI
HK Reg. No. HK-68857 (24 Sep, 2025)

Composition:²

• VAXIGRIP^® is a trivalent influenza vaccine available as a 0.5 ml suspension for injection in a pre-filled syringe. It contains inactivated, split influenza virus strains (H1N1, H3N2-like, and b/brisbane/60/2008-like)

Indication:²

VAXIGRIP^® is indicated for the prevention of influenza disease caused by the two influenza A virus subtypes and the influenza B virus type contained in the vaccine for:

• active immunization of adults, including pregnant women, and children from 6 months of age and older

• passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women

The use of VAXIGRIP^® should be based on official recommendations on vaccination against influenza

References
2. EMC. Vaxigrip suspension for injection in pre-filled syringe. 9 July 2025. Available from: https://www.medicines.org.uk/emc/product/100673/smpc#gref. [Accessed 18 November 2025].